Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 14, 2014 - Issue 2
Submit an article Journal homepage
285
Views
14
CrossRef citations to date
0
Altmetric
Drug Profile

The economics of abiraterone acetate for castration-resistant prostate cancer

Athanasios DellisUniversity Department of Urology, Sismanoglio General Hospital, Athens, Greece;University Department of General Surgery, Areteion Hospital, Athens, Greece
&
Athanasios G PapatsorisUniversity Department of Urology, Sismanoglio General Hospital, Athens, Greece;Correspondence[email protected]
Pages 175-179 | Published online: 25 Feb 2014

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Mohamad Moussa, Athanasios Papatsoris, Despoina Sryropoulou, Mohamed Abou Chakra, Athanasios Dellis & Lazaros Tzelves. (2021) A pharmacoeconomic evaluation of pharmaceutical treatment options for prostate cancer. Expert Opinion on Pharmacotherapy 22:13, pages 1685-1728.
Read now
Mohamad Moussa, Lazaros Lazarou, Athanasios Dellis, Mohamed Abou Chakra & Athanasios Papatsoris. (2021) An up-to-date evaluation of darolutamide for the treatment of prostate cancer. Expert Opinion on Pharmacotherapy 22:4, pages 397-402.
Read now
Mohamad Moussa, Athanasios Papatsoris, Mohamed Abou Chakra, Despoina Sryropoulou & Athanasios Dellis. (2020) Pharmacotherapeutic strategies for castrate-resistant prostate cancer. Expert Opinion on Pharmacotherapy 21:12, pages 1431-1448.
Read now
Yazan K. Barqawi, Matthew E. Borrego, Melissa H. Roberts & Ivo Abraham. (2019) Cost-effectiveness model of abiraterone plus prednisone, cabazitaxel plus prednisone and enzalutamide for visceral metastatic castration resistant prostate cancer therapy after docetaxel therapy resistance. Journal of Medical Economics 22:11, pages 1202-1209.
Read now
Athanasios Dellis & Athanasios Papatsoris. (2016) Cost–effectiveness of denosumab as a bone protective agent for patients with castration resistant prostate cancer. Expert Review of Pharmacoeconomics & Outcomes Research 16:1, pages 5-10.
Read now
Abigail Gee, Amarnath Challapalli & Amit Bahl. (2015) Health-related quality of life in men with metastatic castration–resistant prostate cancer. Expert Review of Pharmacoeconomics & Outcomes Research 15:6, pages 941-949.
Read now

Articles from other publishers (8)

Giuseppe Cirino, Csaba Szabo & Andreas Papapetropoulos. (2023) Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs. Physiological Reviews 103:1, pages 31-276.
Crossref
Thomas Grochtdreis, Hans-Helmut König, Alexander Dobruschkin, Gunhild von Amsberg & Judith Dams. (2018) Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review. PLOS ONE 13:12, pages e0208063.
Crossref
Katherine S. VirgoEthan BaschD. Andrew LoblawThomas K. OliverR. Bryan RumbleMichael A. CarducciLuke NordquistMary-Ellen TaplinEric WinquistEric A. Singer. (2017) Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion. Journal of Clinical Oncology 35:17, pages 1952-1964.
Crossref
Koichi Uemura, Yasuhide Miyoshi, Takashi Kawahara, Shuko Yoneyama, Yusuke Hattori, Jun-ichi Teranishi, Keiichi Kondo, Masatoshi Moriyama, Shigeo Takebayashi, Yumiko Yokomizo, Masahiro Yao, Hiroji Uemura & Kazumi Noguchi. (2016) Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer. BMC Cancer 16:1.
Crossref
Giandomenico Roviello, Maria Rosa Cappelletti, Laura Zanotti, Angela Gobbi, Chiara Senti, Alberto Bottini, Andrea Ravelli, Alberto Bonetta, Giovanni Paganini & Daniele Generali. (2016) Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer. Medicine 95:43, pages e4636.
Crossref
Yasuhide Miyoshi, Kazumi Noguchi, Masahiro Yanagisawa, Masataka Taguri, Satoshi Morita, Ichiro Ikeda, Kiyoshi Fujinami, Takeshi Miura, Kazuki Kobayashi & Hiroji Uemura. (2015) Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer. BMC Cancer 15:1.
Crossref
Paul Mainwaring & Hideyuki Akaza. (2015) Emerging perspectives in prostate cancer: Insights from the 4th Asia Pacific Prostate Cancer Conference. Prostate International 3, pages S1-S4.
Crossref
M E Schutzer, P F Orio, M C Biagioli, D A Asher, H Lomas & D Moghanaki. (2015) A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers. Prostate Cancer and Prostatic Diseases 18:2, pages 96-103.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.